Evaluating how a tumor shrinks or stabilizes during treatment, cancer response is a critical benchmark in oncology. Oncologists use standardized criteria like RECIST to measure this, guiding therapy adjustments. Patients benefit directly, as this assessment informs prognosis and determines if a treatment is effectively controlling their disease, enabling more personalized care.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends